New drugs in thoracic oncology: needs and knowledge – an online ERS Lung Cancer Assembly survey

In the last decade, systemic therapy for advanced lung cancer has become diverse, complex and personalised. These new therapies (monoclonal antibodies, tyrosine kinase inhibitors (TKIs) and immunotherapy) have a far different toxicity profile compared to chemotherapy. Furthermore, clinical indicatio...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:ERJ Open Res
Autors principals: Berghmans, Thierry, Evison, Matthew, Blum, Torsten Gerriet, Peled, Nir, Cadranel, Jacques
Format: Artigo
Idioma:Inglês
Publicat: European Respiratory Society 2018
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6119830/
https://ncbi.nlm.nih.gov/pubmed/30186846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00040-2018
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars